• OUR MISSION

    Improve the health of the people of Wisconsin by supporting and strengthening physicians' ability to practice high-quality patient care in a changing environment.
40::42

Policy Compendium

Policy Compendium Home

View Public Health Policies

MCH-015: Fetal Research

 
Fetal Research: The Wisconsin Medical Society supports fetal research under the following guidelines:

  1. Physicians may participate in fetal research when their activities are part of a competently designed program, under accepted standards of scientific research to produce data that are scientifically valid and significant.
  2. If appropriate, properly performed clinical studies on animals and non-gravid humans should precede any particular fetal research project.
  3. In living fetal research projects, the investigator should demonstrate the same care and concern for the fetus as a physician providing fetal care or treatment in a non-research setting.
  4. All valid federal or state legal requirements should be followed.
  5. There should be no monetary payment to obtain any fetal material for fetal research projects.
  6. Competent peer review committees, review boards or advisory boards should be available, when appropriate, to protect against the possible abuses that could arise in such research.
  7. Research on the so-called “dead fetus,” macerated fetal material, fetal cells, fetal tissue or fetal organs should be in accord with state laws on autopsy and state laws on organ transplantation or anatomical gifts.
  8. In fetal research primarily for treatment of the fetus:
    1. Voluntary and informed consent, in writing, should be given by the gravid woman, acting in the best interest of the fetus.
    2. Alternative treatment or methods of care, if any, should be carefully evaluated and fully explained. If simpler and safer treatment is available, it should be pursued.
  9. In research primarily for treatment of the gravid female:
    1. Voluntary and informed consent, in writing, should be given to the patient.
    2. Alternative treatment or methods of care should be carefully evaluated and fully explained to the patient. If simpler and safer treatment is available, it should be pursued.
    3. If possible, the risk to the fetus should be the least possible, consistent with the gravid female’s need for treatment.
  10. In fetal research involving a viable fetus, primarily for the accumulation of scientific knowledge:
    1. Voluntary and informed consent, in writing, should be given by the gravid woman under circumstances in which a prudent and informed adult would reasonably be expected to give such consent.
    2. The risk to the fetus imposed by the research should be the least possible.
    3. The purpose of the research is the production of data and knowledge that are scientifically significant and that cannot otherwise be obtained.
    4. In this area of research, it is especially important to emphasize that care and concern for the fetus should be demonstrated. There should be no physical abuse of the fetus. (HOD, 0411)*

     
    *Currently under five-year policy review.